Merck, Moderna claim encouraging melanoma vaccine trial results

US pharmaceutical firms Merck and Moderna announced on Wednesday encouraging results from a trial of their experimental vaccine against melanoma, potentially clearing the way for approval. The vaccine, called intismeran autogene, showed “statistically significant and clinically meaningful improvements” for skin cancer patients when used with Merck’s Keytruda treatment, the companies said in a statement. Unlike conventional vaccines, so-called therapeutic vaccines like intismeran treat rather...

  General   Aug 19, 2026   0   6  Add to Reading List
Merck, Moderna claim encouraging melanoma vaccine trial results


















US pharmaceutical firms Merck and Moderna announced on Wednesday encouraging results from a trial of their experimental vaccine against melanoma, potentially clearing the way for approval. The vaccine, called intismeran autogene, showed “statistically significant and clinically meaningful improvements” for skin cancer patients when used with Merck’s Keytruda treatment, the companies said in a statement. Unlike conventional vaccines, so-called therapeutic vaccines like intismeran treat rather...
Read Original   

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow